Our previous analysis of tumour immunohistochemical features of UV carriers suggested disparate results for two tumours from G1738R carriers, a result we confirm here with more detailed immunohistochemical analysis of basal markers of the BRCA1 mutation phenotype. This evidence concerns the gene BRCA1 and neoplasm.